학술논문

Prediction of Causal Candidate Genes in Coronary Artery Disease Loci
Document Type
article
Source
Arteriosclerosis Thrombosis and Vascular Biology. 35(10)
Subject
Heart Disease
Cardiovascular
Atherosclerosis
Biotechnology
Heart Disease - Coronary Heart Disease
Human Genome
Genetics
Aetiology
2.1 Biological and endogenous factors
Coronary Artery Disease
Female
Genetic Loci
Genetic Predisposition to Disease
Genetic Variation
Genome-Wide Association Study
Humans
Male
MicroRNAs
Polymorphism
Single Nucleotide
Predictive Value of Tests
Promoter Regions
Genetic
coronary artery disease
genome-wide association study
microRNAs
single-nucleotide polymorphism
systems biology
Leducq Consortium CAD Genomics‡
Cardiorespiratory Medicine and Haematology
Clinical Sciences
Cardiovascular System & Hematology
Language
Abstract
ObjectiveGenome-wide association studies have to date identified 159 significant and suggestive loci for coronary artery disease (CAD). We now report comprehensive bioinformatics analyses of sequence variation in these loci to predict candidate causal genes.Approach and resultsAll annotated genes in the loci were evaluated with respect to protein-coding single-nucleotide polymorphism and gene expression parameters. The latter included expression quantitative trait loci, tissue specificity, and miRNA binding. High priority candidate genes were further identified based on literature searches and our experimental data. We conclude that the great majority of causal variations affecting CAD risk occur in noncoding regions, with 41% affecting gene expression robustly versus 6% leading to amino acid changes. Many of these genes differed from the traditionally annotated genes, which was usually based on proximity to the lead single-nucleotide polymorphism. Indeed, we obtained evidence that genetic variants at CAD loci affect 98 genes which had not been linked to CAD previously.ConclusionsOur results substantially revise the list of likely candidates for CAD and suggest that genome-wide association studies efforts in other diseases may benefit from similar bioinformatics analyses.